HEALTH● LOW2h ago · Sep 24, 2026, 8:32 PM
Merck Welireg, Eisai Lenvima combo approved for kidney cancer
Seeking Alpha Tech · global
A combination therapy involving Merck's Welireg and Eisai's Lenvima has received approval for treating kidney cancer. This development offers a new treatment option for patients with this condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoUNFPA ESARO | Choice no matter the context : How contraception changes livesesaro.unfpa.org · UgandaHEALTH1h agoU.S. pledges an additional $267 million to contain fast-spreading EbolaWashington Post WorldHEALTH1h agoUS High Schoolers Show Improved Mental HealthHuman ProgressHEALTH1h agoIvory Coast Expands Medical Drone ServiceHuman Progress